In our cell-cycle analytical assays, the sub-G1 cell population in GBM-Znf179( + ) cells was relatively lower than those in GBM-Znf179(−) cells, yet the difference was not significant (Fig. 4D,E). This evidence concerns the gene RNF112 and glioblastoma.